Oscotec Inc. (KOSDAQ:039200)

South Korea flag South Korea · Delayed Price · Currency is KRW
56,000
-1,500 (-2.61%)
Mar 20, 2026, 3:30 PM KST
Market Cap2.14T +111.4%
Revenue (ttm)23.23B -27.3%
Net Income-13.14B
EPS-343.51
Shares Out38.26M
PE Ration/a
Forward PE87.64
Dividendn/a
Ex-Dividend Daten/a
Volume481,832
Average Volume392,603
Open58,500
Previous Close57,500
Day's Range55,100 - 59,000
52-Week Range25,000 - 66,000
Beta1.45
RSI54.88
Earnings DateMar 26, 2026

About Oscotec

Oscotec Inc. operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses. It develops SKI-O-703, a SYK inhibitor that is in Phase 2 clinical trials to treat rheumatoid arthritis and idiopathic thrombocytopenic purpura; SKI-G-801, a selective FLT3/AXL inhibitor, which is in Phase I clinical trial for the treatment of acute myeloid leukemia, as well as other solid tumors; and lazertinib, a 3rd generation EGFR inhibitor that is in Phase 3 clinical trials... [Read more]

Sector Healthcare
Founded 1998
Employees 53
Stock Exchange KOSDAQ
Ticker Symbol 039200
Full Company Profile

Financial Performance

Financial Statements